Artificial Intelligence in Life Science Market, By Offering, By Analytics, By Applicatio, By End User, By Enabling Technology, By Distribution Channel, By Geography

Description

Artificial Intelligence in Life Science Market is estimated to be valued at USD 3.73 Bn in 2025 and is expected to reach USD 18.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.73 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	25.30%	2032 Value Projection:	USD 18.09 Bn

The global artificial intelligence in life science market represents a transformative convergence of cutting-edge computational technologies and biological research, fundamentally reshaping how pharmaceutical companies, biotechnology firms, and research institutions approach drug discovery, clinical trials, and patient care. This dynamic market encompasses the application of machine learning algorithms, natural language processing, computer vision, and predictive analytics to accelerate scientific breakthroughs in areas such as genomics, proteomics, drug development, and personalized medicine.

AI technologies are revolutionizing traditional life science methodologies by enabling researchers to analyze vast datasets, identify novel drug targets, optimize clinical trial designs, and predict treatment outcomes with unprecedented accuracy and speed. The integration of AI in life sciences is driven by the exponential growth of biological data, increasing computational power, and the urgent need to reduce the time and cost associated with bringing new therapies to market. From virtual screening of molecular compounds to AI-powered diagnostic tools and robotic laboratory automation, these technologies are creating new paradigms for scientific discovery and healthcare delivery, positioning artificial intelligence as an indispensable catalyst for innovation in the modern life sciences ecosystem.

Market Dynamics

The global artificial intelligence in life science market is propelled by several key drivers that are fundamentally transforming the industry landscape. The exponential increase in biological data generation, including genomic sequencing data, clinical records, and biomarker information, necessitates sophisticated AI algorithms capable of processing and extracting meaningful insights from complex datasets. The rising costs and extended timelines associated with traditional drug development processes, which can exceed USD 2.6 billion and span 10-15 years, are driving pharmaceutical companies to adopt AI solutions that can significantly reduce both financial burden and time-to-market for new therapeutics. Additionally, the growing emphasis on personalized medicine and precision therapeutics is creating substantial demand for AI-powered tools that can analyze patient-specific data to optimize treatment protocols.

However, the market faces notable restraints including stringent regulatory frameworks that require extensive validation of AI algorithms before clinical implementation, data privacy concerns related to patient information handling, and the shortage of skilled professionals who can effectively bridge the gap between AI technology and life science applications.

Furthermore, the high initial investment costs for implementing AI infrastructure and the challenge of integrating AI systems with existing laboratory and clinical workflows present significant barriers for smaller organizations. Despite these challenges, the market presents tremendous opportunities driven by increasing venture capital investments in AI-driven life science startups, growing collaborations between technology giants and pharmaceutical companies, expanding applications in areas such as medical imaging and diagnostic pathology, and the accelerating adoption of cloud-based AI platforms that democratize access to advanced computational capabilities across organizations of all sizes.

Key Features of the Study

This report provides in-depth analysis of the global artificial intelligence in life science market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial intelligence in life science market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Insilico Medicine, Atomwise, Exscientia, Schrodinger, Recursion Pharmaceuticals, BenevolentAI, Cyclica, Iktos, Owkin, Evogene, Anima Biotech, Generate Biomedicines, Nimbus Therapeutics, DeepMind/Isomorphic Labs, and IBM Watson Health
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial intelligence in life science market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in life science market

Market Segmentation

Offering Insights (Revenue, USD Bn, 2020 - 2032)
- Software (algorithms, AI-powered platforms, modules, etc.)
- Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
- Services (consulting, integration, training, maintenance, etc.)
Deployment Model Insights (Revenue, USD Bn, 2020 - 2032)
- Cloud Based
- On-premise
Analytics Insights (Revenue, USD Bn, 2020 - 2032)
- Descriptive/Reporting
- Predictive
- Prescriptive/Decision support
- Generative/Synthetic data/AI-driven molecule generation
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Discovery and Development
- Clinical Trials Design and Optimization
- Medical Diagnosis and Imaging/Biomarker Detection
- Precision and Personalized Medicine
- Biotechnology/Bioprocessing/Omics
- Patient Monitoring and Real-World Evidence (RWE)
- Regulatory/Safety and Pharmacovigilance
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)/Clinical Research Firms
- Medical Device Manufacturers
- Academic and Research Institutions
- Healthcare Providers (Hospitals/Diagnostic Clinics)
- Regulatory Agencies and Safety Boards
Enabling Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Machine Learning/Statistical Models
- Natural Language Processing (NLP)/Text Mining
- Computer Vision/Imaging AI
- Deep Learning/Neural Networks
- Hybrid and Multi-modal AI(fusion of modalities)
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Insilico Medicine
- Atomwise
- Exscientia
- Schrodinger
- Recursion Pharmaceuticals
- BenevolentAI
- Cyclica
- Iktos
- Owkin
- Evogene
- Anima Biotech
- Generate Biomedicines
- Nimbus Therapeutics
- DeepMind/Isomorphic Labs
- IBM Watson Health

Product Code: CMI8771

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Artificial Intelligence in Life Science Market, By Offering
- Global Artificial Intelligence in Life Science Market, By Deployment Model
- Global Artificial Intelligence in Life Science Market, By Analytics
- Global Artificial Intelligence in Life Science Market, By Application
- Global Artificial Intelligence in Life Science Market, By End User
- Global Artificial Intelligence in Life Science Market, By Enabling Technology
- Global Artificial Intelligence in Life Science Market, By Distribution Channel
- Global Artificial Intelligence in Life Science Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Artificial Intelligence in Life Science Market, By Offering, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Software (algorithms, AI-powered platforms, modules, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Services (consulting, integration, training, maintenance, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Intelligence in Life Science Market, By Deployment Model, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cloud Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
On-premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Intelligence in Life Science Market, By Analytics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Descriptive/Reporting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Predictive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prescriptive/Decision support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Generative/Synthetic data/AI-driven molecule generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Intelligence in Life Science Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinical Trials Design and Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Diagnosis and Imaging/Biomarker Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Precision and Personalized Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biotechnology/Bioprocessing/Omics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patient Monitoring and Real-World Evidence (RWE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Regulatory/Safety and Pharmacovigilance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Intelligence in Life Science Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research Organizations (CROs)/Clinical Research Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Healthcare Providers (Hospitals/Diagnostic Clinics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Regulatory Agencies and Safety Boards
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Intelligence in Life Science Market, By Enabling Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Machine Learning/Statistical Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Natural Language Processing (NLP)/Text Mining
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Computer Vision/Imaging AI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Deep Learning/Neural Networks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hybrid and Multi-modal AI(fusion of modalities)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Artificial Intelligence in Life Science Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Artificial Intelligence in Life Science Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive landscape

Insilico Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Atomwise
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exscientia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Schrodinger
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Recursion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BenevolentAI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cyclica
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Iktos
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Owkin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evogene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Anima Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Generate Biomedicines
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nimbus Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DeepMind/Isomorphic Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
IBM Watson Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About Us